218 related articles for article (PubMed ID: 29110053)
41. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma.
Kambadakone AR; Zaheer A; Le O; Bhosale P; Meier J; Guimaraes AR; Shah Z; Hough DM; Mannelli L; Soloff E; Friedman A; Tamm E
Abdom Radiol (NY); 2018 Feb; 43(2):245-252. PubMed ID: 29277858
[TBL] [Abstract][Full Text] [Related]
42. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings.
Badiyan SN; Molitoris JK; Chuong MD; Regine WF; Kaiser A
Surg Oncol Clin N Am; 2017 Jul; 26(3):431-453. PubMed ID: 28576181
[TBL] [Abstract][Full Text] [Related]
43. CT texture analysis for the presurgical prediction of superior mesenteric-portal vein invasion in pancreatic ductal adenocarcinoma: comparison with CT imaging features.
Chen F; Zhou Y; Qi X; Xia W; Zhang R; Zhang J; Gao X; Zhang L
Clin Radiol; 2021 May; 76(5):358-366. PubMed ID: 33581837
[TBL] [Abstract][Full Text] [Related]
44. Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning.
Zaky AM; Wolfgang CL; Weiss MJ; Javed AA; Fishman EK; Zaheer A
Radiographics; 2017; 37(1):93-112. PubMed ID: 27885893
[TBL] [Abstract][Full Text] [Related]
45. What Can We Learn About Pancreatic Adenocarcinoma from Imaging?
Rosenthal M; Schawkat K; Muftah M; Jajoo K
Hematol Oncol Clin North Am; 2022 Oct; 36(5):911-928. PubMed ID: 36265990
[TBL] [Abstract][Full Text] [Related]
46. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
47. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
[TBL] [Abstract][Full Text] [Related]
48. Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.
Qiu H; Wild AT; Wang H; Fishman EK; Hruban RH; Laheru DA; Kumar R; Hacker-Prietz A; Tuli R; Tryggestad E; Schulick RD; Cameron JL; Edil BH; Pawlik TM; Wolfgang CL; Herman JM
Radiother Oncol; 2012 Aug; 104(2):167-72. PubMed ID: 22883106
[TBL] [Abstract][Full Text] [Related]
49. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
50. Resection of multiple invasive pancreatic ductal adenocarcinomas: A diagnostic dilemma distinguishing multicentric carcinogenesis from intrapancreatic metastasis.
Ohike N; Norose T; Takano Y; Niiya F; Nagahama M; Matsuo K; Tanaka K; Furukawa T
Pathol Int; 2020 Aug; 70(8):588-590. PubMed ID: 32515154
[No Abstract] [Full Text] [Related]
51. [PET and PET-CT of malignant tumors of the exocrine pancreas].
Reske SN
Radiologe; 2009 Feb; 49(2):131-6. PubMed ID: 19219476
[TBL] [Abstract][Full Text] [Related]
52. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
53. Locally advanced pancreatic cancer: An emerging entity.
O Kane GM; Knox JJ
Curr Probl Cancer; 2018; 42(1):12-25. PubMed ID: 29153290
[TBL] [Abstract][Full Text] [Related]
54. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma.
Rauth S; Karmakar S; Shah A; Seshacharyulu P; Nimmakayala RK; Ganguly K; Bhatia R; Muniyan S; Kumar S; Dutta S; Lin C; Datta K; Batra SK; Ponnusamy MP
Mol Cell Biol; 2021 Nov; 41(12):e0013521. PubMed ID: 34570619
[TBL] [Abstract][Full Text] [Related]
55. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
[TBL] [Abstract][Full Text] [Related]
56. Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
Wilkowski R; Thoma M; Weingandt H; Dühmke E; Heinemann V
JOP; 2005 May; 6(3):216-30. PubMed ID: 15883472
[TBL] [Abstract][Full Text] [Related]
57. Endoscopic ultrasound-guided fine needle aspiration features of a pancreatic neoplasm with predominantly intraductal growth and prominent tubular cytomorphology: intraductal tubular carcinoma of the pancreas?
Aslan DL; Jessurun J; Gulbahce HE; Pambuccian SE; Adsay V; Mallery JS
Diagn Cytopathol; 2008 Nov; 36(11):833-9. PubMed ID: 18831024
[No Abstract] [Full Text] [Related]
58. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.
Koay EJ; Lee Y; Cristini V; Lowengrub JS; Kang Y; Lucas FAS; Hobbs BP; Ye R; Elganainy D; Almahariq M; Amer AM; Chatterjee D; Yan H; Park PC; Rios Perez MV; Li D; Garg N; Reiss KA; Yu S; Chauhan A; Zaid M; Nikzad N; Wolff RA; Javle M; Varadhachary GR; Shroff RT; Das P; Lee JE; Ferrari M; Maitra A; Taniguchi CM; Kim MP; Crane CH; Katz MH; Wang H; Bhosale P; Tamm EP; Fleming JB
Clin Cancer Res; 2018 Dec; 24(23):5883-5894. PubMed ID: 30082477
[TBL] [Abstract][Full Text] [Related]
59. CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy.
Ciaravino V; Cardobi N; DE Robertis R; Capelli P; Melisi D; Simionato F; Marchegiani G; Salvia R; D'Onofrio M
Anticancer Res; 2018 Aug; 38(8):4889-4895. PubMed ID: 30061265
[TBL] [Abstract][Full Text] [Related]
60. Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility.
Cattaneo GM; Passoni P; Sangalli G; Slim N; Longobardi B; Mancosu P; Bettinardi V; Di Muzio N; Calandrino R
Radiother Oncol; 2010 Dec; 97(3):525-9. PubMed ID: 20826027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
